PHARMACIE SOLVAY
The computed 12-month bankruptcy probability of PHARMACIE SOLVAY is 1.5% (moderate). The 2024 annual accounts show negative equity (€-120k) and a net result of €-32k. Equity is growing by ~4.8% per year across the filed fiscal years. Its solvency ranks better than 11% of 873 sector peers (fiscal year 2024). The company has been active since 2016 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €-120k |
| Net result | €-32k |
| Staff (FTE) | 8.9 |
| Better than sector | 11% |
Mixed profile: strong on profitability, weaker on health.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | -21.7% | 17.2% | |
| Net result | €-32k | €14k | |
| Equity | €-120k | €99k | |
| Gross operating margin | €415k | €213k | |
| Staff costs | €424k | €221k |
Show 9 other metrics
| Fiscal year | 2024 |
|---|---|
| Deposit | volledig |
| Revenue | - |
| EBITDA | €-10k |
| Net profit | €-32k |
| Cash flow | €-9k |
| Staff costs | €424k |
| Income taxes | - |
| Dividends | - |
| Total assets | €555k |
| Equity | €-120k |
| Debt | €675k |
| of which ≤ 1y | €675k |
| of which > 1y | - |
| Working capital | €-240k |
| Employees (FTE) | 8.9 |
| 2024 | |
|---|---|
| Current ratio | 0.64 |
| Quick ratio | 0.31 |
| Working capital ratio | -43.3% |
| Solvency | -21.7% |
| Debt / equity | -5.62 |
| Long-term debt ratio | - |
| Interest coverage | -4.46 |
| Gross margin | - |
| Net margin | - |
| ROA | -5.8% |
| ROE | 26.7% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (22 line items)
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €555k |
| Fixed assets | 21/28 | €120k |
| Tangible fixed assets | 22/27 | €109k |
| Financial fixed assets | 28 | €11k |
| Current assets | 29/58 | €435k |
| Stocks & contracts in progress | 3 | €226k |
| Amounts receivable within one year | 40/41 | €204k |
| Cash & bank | 54/58 | €4k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €555k |
| Equity | 10/15 | €-120k |
| Contributions / capital | 10/11 | €19k |
| Accumulated profits (losses) | 14 | €-139k |
| Amounts payable | 17/49 | €675k |
| Amounts payable within one year | 42/48 | €675k |
| Trade debts payable within one year | 44 | €119k |
| Income statement | ||
| Gross operating margin | 9900 | €415k |
| Operating result | 9901 | €-33k |
| Financial income | 75 | €3k |
| Financial charges | 65 | €2k |
| Result before taxes | 9903 | €-32k |
| Net result for the period | 9904 | €-32k |
| Result to be appropriated | 9905 | €-32k |
| NACE primary | Detailhandel in farmaceutische producten(47730) |
| Legal form | Private limited company(610) |
| Incorporation | 21-12-2016 |
| Status | Active |
| Postal code | 4040 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62051D1723/00N002 | Wallonia | 413 m² | 1 · 71 m² | 10.9 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
10-10-2023 Capital increase
Technical details
{
"events": [
{
"kind": "statutory_reserve_release",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "suppress"
},
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": "nominal",
"share_class": null,
"n_new_shares": 100,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Ronald PLATEUS",
"firm_city": null,
"firm_name": null,
"office_city": "Seraing",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2023-10-10",
"filing_date": "2023-10-06",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_generale_extraordinaire",
"act_date": "2023-09-19",
"unanimous": true,
"under_authorized_capital": false,
"underlying_resolution_date": "2023-09-19"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0667.943.582",
"name_full": "PHARMACIE SOLVAY",
"legal_form": "SRL",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"shareholders_after": [],
"share_classes_after": []
}| Legal nameFR | PHARMACIE SOLVAY |